Medicinal composition for treating chronic liver disease and application thereof

The present invention discloses a method of treating chronic liver disease a pharmaceutical composition, the weight ratio of 3 to 6 to 1 astragalosides and glycyrrhizic acid composition, by using the classical animal model test and verification, the pharmaceutical compositions of the invention can significantly reduce the reverse liver tissue collagen content, reducing the degree of liver damage and fibrosis of liver, hepatic fibrosis can be improved, effectively prevent the development of hepatic fibrosis and liver fibrosis model rats promote the more effective than the individual components alone effect, useful for the treatment and prevention of various chronic hepatitis, liver fibrosis, cirrhosis and other diseases. The pharmaceutical compositions of the present invention may be formulated as tablets, granules, capsules and the like for oral solid preparation.